Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
65 /100
HIGH RISK
Score updated Aug 28, 2026

ZNTL — Zentalis Pharmaceuticals, Inc. Dilution Risk Tracker

Track ZNTL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ZNTL — Get alerts when the score changes →

As of August 28, 2026, Zentalis Pharmaceuticals, Inc. (ZNTL) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Zentalis Pharmaceuticals, Inc. has a market capitalization of $284.75M, 71.67M shares outstanding, 105 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
95
📊 Float Risk
30
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 34%
💰 Capital Raise model 55%
• Critical: only 1.8 months cash remaining
🔄 Reverse Split model est. 15%
• Only 2 months cash — financial pressure
📉 Score Deterioration model 10%
• Score in HIGH risk zone (65/100)
🔔 Track ZNTL — Get forecast alerts →

Market Data

Market Cap$284.75M
Shares Outstanding71.67M
Float48.84M
Cash$24.78M
Debt$34.65M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 22.4% shares (2026Q1 vs prior)
105 institutional holders · 51.80M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 4.62M shares
#2 Squadron Capital Management LLC 4.03M shares
#3 5AM Venture Management, LLC 3.95M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest5.58M
Days to Cover4.2
% of Float11.4%
FINRA data as of Jul 31, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news
Track ZNTL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ZNTL — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

ALLO AMSS APC APRE AVEX CAMP CERO CLRO CRIS DMRA

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ZNTL
ZNTL FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.